您的购物车当前为空
别名 雷贝拉唑钠, Rebeprazole sodium, LY307640 sodium, Habeprazole Sodium, Dexrabeprazole Sodium, Aciphex Sodium
Rabeprazole sodium (Habeprazole Sodium) 是一种质子泵抑制剂,不可逆地抑制胃 H+/K+-ATPase,可研究胃溃疡和胃食管反流。它诱导细胞凋亡,也抑制尿苷核苷核糖水解酶 ,IC50为 0.3 μM。

Rabeprazole sodium (Habeprazole Sodium) 是一种质子泵抑制剂,不可逆地抑制胃 H+/K+-ATPase,可研究胃溃疡和胃食管反流。它诱导细胞凋亡,也抑制尿苷核苷核糖水解酶 ,IC50为 0.3 μM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 100 mg | ¥ 108 | In Stock | |
| 500 mg | ¥ 198 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 113 | In Stock |
Rabeprazole sodium 相关产品
| 产品描述 | Rabeprazole sodium (Habeprazole Sodium) is a 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of stomach ulcers and Zollinger-Ellison syndrome. The drug inhibits H(+)-K(+)-exchanging ATPase which is found in gastric parietal cells. |
| 靶点活性 | UNH:0.3 μM (IC50) |
| 体外活性 | 给予rabeprazole显著降低了MKN-28细胞的活力。rabeprazole的暴露显著诱导AGS细胞发生凋亡。rabeprazole完全抑制了MKN-28细胞中ERK 1/2的磷酸化,而在KATO III或MKN-45细胞中未观察到同样的效果。rabeprazole能有效抑制胃癌细胞中ERK 1/2的磷酸化。因此,rabeprazole通过失活ERK1/2信号通路,能减弱人类胃癌细胞的细胞活力[2]。 |
| 体内活性 | Rabeprazole似乎不会加剧胃切除大鼠的骨代谢障碍,反而缓解了TG诱导的BMD下降[1]。 |
| 细胞实验 | Rabeprazole is administrated to three gastric cancer cell lines, KATO III, MKN-28 and MKN-45, at a dosage of 0.2 mM for 16 h. The viability of these cells is determined by a trypan blue exclusion assay.(Only for Reference) |
| 别名 | 雷贝拉唑钠, Rebeprazole sodium, LY307640 sodium, Habeprazole Sodium, Dexrabeprazole Sodium, Aciphex Sodium |
| 分子量 | 381.42 |
| 分子式 | C18H20N3NaO3S |
| CAS No. | 117976-90-6 |
| Smiles | c12c([n-]c(n1)S(=O)Cc1c(c(ccn1)OCCCOC)C)cccc2.[Na+] |
| 密度 | 0.45~0.55 g/ml |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 58.82 mg/mL (154.21 mM), Sonication is recommended. H2O: 1.34 mg/mL (3.51 mM), Sonication is recommended. Ethanol: 71 mg/mL (186.15 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.24 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO/Ethanol
DMSO/Ethanol
| |||||||||||||||||||||||||||||||||||||||||
评论内容